Minimally Invasive Epilepsy Surgery Symposium

Thursday, February 5, 2026, 8:00 AM - Friday, February 6, 2026, 6:00 PM, Jan and Dan Duncan Neurological Research Institute (NRI) Conference Center, Houston, TX


AMA PRA Category 1 Credits™ (15.00 hours), Non-Physician Attendance (15.00 hours)

This comprehensive symposium will bring together leading experts in pediatric epilepsy surgery to explore the evolving landscape of minimally invasive techniques. With the growing adoption of surgical strategies such as SEEG, RNS, DBS, laser ablation, and gene therapy, this course is designed to equip pediatric neurologists and epileptologists, neurosurgeons, and emerging physicians with the latest clinical insights and translational advancements in the field. Through in-depth sessions, participants will examine the expanded indications for minimally invasive epilepsy surgery in children, including those with tuberous sclerosis complex (TSC), Lennox-Gastaut syndrome (LGS), and infantile spasms (IS). Attendees will gain practical knowledge in surgical planning using SEEG, MEG, PET, rsfMRI, and other advanced imaging modalities, as well as the interpretation of invasive and non-invasive localization data. Discussions will cover emerging technologies such as robotics, RNS programming, DBS optimization, TMS applications, and intrathecal AED therapy. Experts will also address pre- and post-operative considerations including anesthesia, referral logistics, and complication management. Special emphasis will be placed on transforming discoveries into therapies, narrowing treatment gaps, and improving surgical outcomes for pediatric populations.

1. Describe current minimally invasive surgical approaches for the treatment of pediatric epilepsy, including laser ablation, SEEG-guided resections, and responsive neurostimulation.
2. Compare indications, risks, and benefits of minimally invasive techniques versus traditional open epilepsy surgeries.
3. Interpret advanced neuroimaging and electrophysiologic data to guide patient selection and surgical planning.
4. Apply a multidisciplinary framework to assess candidacy and develop individualized treatment plans for children with drug-resistant epilepsy.
5. Evaluate emerging technologies and procedural innovations in the field of minimally invasive epilepsy surgery.
6. Identify opportunities to enhance postoperative outcomes and reduce complications through preoperative planning and intraoperative decision-making.

Texas Children’s Hospital is accredited by the Texas Medical Association to provide continuing medical education for physicians. Texas Children’s Hospital designates this Live Activity activity for a maximum of 15.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Texas Children's Hospital reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
Texas Children's Hospital is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Texas Children's Hospital adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Texas Children's Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible company (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.